Tools content (print, share, increase/decrease text size):


Our websites


Middle area:

Maximizing value

Well-balanced worldwide presence

As of December 31, 2011, we had a global sales force of 32,874 representatives: 9,866 in Europe, 4,866 in the United States, and 18,142 in the rest of the world.

Sanofi has a commercial presence in approximately 100 countries, and our products are available in more
than 170. Our main markets in terms of net sales are, respectively:

  • Emerging Markets* represent 30.3% of our net sales. We are the leading healthcare company in emerging markets.
  • The United States represent 29.8% of our net sales; we rank thirteenth with a market share of 3.1%.
  • Western Europe represents 27.3% of our net sales; we are the leading pharmaceutical company in France where our market share is 9.9%, and we rank fifth in Germany with a 4.6% market share.
  • Japan represents 8.6% of our net sales; our market share is 3.4%.

* We define “Emerging Markets” as the world excluding the United States, Canada, Western Europe (France, Germany, UK, Italy, Spain, Greece, Cyprus, Malta, Belgium, Luxemburg, Portugal, the Netherlands, Austria, Switzerland, Ireland, Finland, Norway, Iceland, Sweden and Denmark), Japan, Australia and New Zealand.


To find out more visit the section:


Right area:

Partners to your ideas - Submit your project
Available opportunities - Out-licensing

Upcoming events

American Diabetes Association (ADA) 73rd Scientific Sessions 2013

June 21-25, 2013
Chicago, IL, United States - USA


© Sanofi 2004-2014 - All rights reserved - Update: June 23, 2014